肝肾综合征-话题@MedSci

#肝肾综合征#

7篇内容 | 1624人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2175227, encodeId=58cc21e52274d, content=<a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a> <a href='/topic/show?id=7cd15239687' target=_blank style='color:#2F92EE;'>#急性肾损伤#</a> <a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a> <a href='/topic/show?id=097710863e73' target=_blank style='color:#2F92EE;'>#连续肾脏替代治疗#</a>, objectTitle=eGastroenterology：肝肾综合征诊断与治疗的进展：关于HRS-AKI和肝移植的深入见解, objectType=article, longId=805281, objectId=b5ff80528133, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231207/eefadacae7f243358ad96094f5200765.jpg, objectUrl=/article/show_article.do?id=b5ff80528133, replyNumber=0, likeNumber=111, createdTime=2023-12-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=b5ff80528133, moduleTitle=eGastroenterology：肝肾综合征诊断与治疗的进展：关于HRS-AKI和肝移植的深入见解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ff80528133)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2115233, encodeId=5d212115233a1, content=<a href='/topic/show?id=591e10528895' target=_blank style='color:#2F92EE;'>#临床虚弱量表#</a>测试的<a href='/topic/show?id=812788522b7' target=_blank style='color:#2F92EE;'>#虚弱#</a>程度是<a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a>患者<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a>的危险因素<a href='/topic/show?id=bfe3961369b' target=_blank style='color:#2F92EE;'>#量表#</a>, objectTitle=Clinical and Translational Gastroenterology: 临床虚弱量表测试的虚弱程度是肝硬化患者肝肾综合征的危险因素, objectType=article, longId=743148, objectId=ac61e4314815, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=ac61e4314815, replyNumber=0, likeNumber=149, createdTime=2023-02-18, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ac61e4314815, moduleTitle=Clinical and Translational Gastroenterology: 临床虚弱量表测试的虚弱程度是肝硬化患者肝肾综合征的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac61e4314815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2092808, encodeId=b6322092808de, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准的<a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#创新药物#</a>，这里看到常见病，如<a href='/topic/show?id=91cf549e3f1' target=_blank style='color:#2F92EE;'>#抑郁症#</a>，<a href='/topic/show?id=13032e051f7' target=_blank style='color:#2F92EE;'>#便秘#</a>的治疗，也有<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>，如<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>的<a href='/topic/show?id=567041e8055' target=_blank style='color:#2F92EE;'>#基因治疗#</a>上市。还有<a href='/topic/show?id=0eca955681e' target=_blank style='color:#2F92EE;'>#酶替代治疗#</a><a href='/topic/show?id=e6b910492475' target=_blank style='color:#2F92EE;'>#Xenpozyme#</a>，<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>治疗成人<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a> (HRS)等，整体来说，创新药呈现是加速发展的趋势。, objectTitle=FDA在2022年第三季度批准了哪些创新药（下）？, objectType=article, longId=742666, objectId=b6c8e42666e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221009/ab2e59afdf774f8881a31e168706d9f7.jpg, objectUrl=/article/show_article.do?id=b6c8e42666e2, replyNumber=0, likeNumber=190, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6c8e42666e2, moduleTitle=FDA在2022年第三季度批准了哪些创新药（下）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6c8e42666e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620928, encodeId=0e1516209283e, content=<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a>, objectTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, objectType=article, longId=211429, objectId=be23211429df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be23211429df, replyNumber=0, likeNumber=91, createdTime=2021-05-18, rootId=0, userName=klivis, userId=c09a20165309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be23211429df, moduleTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be23211429df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620927, encodeId=a3cf162092e24, content=<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a>, objectTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, objectType=article, longId=208183, objectId=5b2d208183e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b2d208183e4, replyNumber=0, likeNumber=84, createdTime=2021-03-10, rootId=0, userName=klivis, userId=c09a20165309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b2d208183e4, moduleTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b2d208183e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620926, encodeId=bbed16209264c, content=<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a>, objectTitle=J Gen Intern Med：治疗肝肾综合征就用…, objectType=article, longId=128607, objectId=de4712860e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de4712860e9e, replyNumber=0, likeNumber=102, createdTime=2018-02-04, rootId=0, userName=klivis, userId=c09a20165309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de4712860e9e, moduleTitle=J Gen Intern Med：治疗肝肾综合征就用…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de4712860e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620925, encodeId=012516209252e, content=<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a>, objectTitle=J Gen Intern Med：血管活性药物在治疗肝肾综合征效果的比较, objectType=article, longId=128608, objectId=197a128608da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=197a128608da, replyNumber=0, likeNumber=107, createdTime=2018-02-04, rootId=0, userName=klivis, userId=c09a20165309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=197a128608da, moduleTitle=J Gen Intern Med：血管活性药物在治疗肝肾综合征效果的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=197a128608da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620924, encodeId=d23a162092432, content=<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a>, objectTitle=Aliment Pharmacol Ther：肝肾综合征1型：特利加压素+白蛋白vs安慰剂+白蛋白, objectType=article, longId=103153, objectId=130710315300, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130710315300, replyNumber=0, likeNumber=84, createdTime=2017-06-25, rootId=0, userName=klivis, userId=c09a20165309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130710315300, moduleTitle=Aliment Pharmacol Ther：肝肾综合征1型：特利加压素+白蛋白vs安慰剂+白蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=130710315300)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝肾综合征

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肝硬化# #急性肾损伤# #肝肾综合征# #连续肾脏替代治疗#

eGastroenterology：肝肾综合征诊断与治疗的进展：关于HRS-AKI和肝移植的深入见解

2023-12-16发表于威斯康星

showtest (审核中...)

前往app查看评论内容

#临床虚弱量表#测试的#虚弱#程度是#肝硬化#患者#肝肾综合征#的危险因素#量表#

Clinical and Translational Gastroenterology: 临床虚弱量表测试的虚弱程度是肝硬化患者肝肾综合征的危险因素

2023-02-18发表于上海

lifestar (审核中...)

前往app查看评论内容

#FDA#批准的#创新药物#，这里看到常见病，如#抑郁症#，#便秘#的治疗，也有#罕见病#，如#β地中海贫血#的#基因治疗#上市。还有#酶替代治疗##Xenpozyme#，#特利加压素#治疗成人#肝肾综合征# (HRS)等，整体来说，创新药呈现是加速发展的趋势。

FDA在2022年第三季度批准了哪些创新药（下）？

2022-10-10

klivis (审核中...)

前往app查看评论内容

#肝肾综合征#

Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关

2021-05-18

klivis (审核中...)

前往app查看评论内容

#肝肾综合征#

NEJM：特利加压素联合白蛋白治疗1型肝肾综合征

2021-03-10

klivis (审核中...)

前往app查看评论内容

#肝肾综合征#

J Gen Intern Med：治疗肝肾综合征就用…

2018-02-04

klivis (审核中...)

前往app查看评论内容

#肝肾综合征#

J Gen Intern Med：血管活性药物在治疗肝肾综合征效果的比较

2018-02-04

klivis (审核中...)

前往app查看评论内容

#肝肾综合征#

Aliment Pharmacol Ther：肝肾综合征1型：特利加压素+白蛋白vs安慰剂+白蛋白

2017-06-25

科室
- - 订阅+
  - 更多科室
工具
服务